8-K: Current report filing
Published on January 5, 2006
OMEGA
HEALTHCARE INVESTORS ANNOUNCES
EXPIRATION
OF CONSENT DATE, EXECUTION OF SUPPLEMENTAL INDENTURE,
AND
REDEMPTION DATE FOR ITS 6.95% NOTES DUE 2007
TIMONIUM,
MARYLAND - December 30, 2005 -
Omega
Healthcare Investors, Inc. (NYSE:OHI) (“Omega”) announced
today that in connection with its current tender offer and consent solicitation
for all of its outstanding 6.95% notes due 2007 (the “Notes”), it was in receipt
of tenders and consents representing 79.3% of the aggregate principal amount
of
the Notes outstanding. The tendered notes were accepted for purchase by Omega.
The total consideration to be paid to holders who have validly tendered their
Notes and delivered their consents will be $1,031.02 for each $1,000 principal
amount of Notes validly tendered and not validly revoked, which includes a
consent payment of $30.00 per $1,000 principal amount of Notes. The
consideration for the tendered Notes and consents will be paid from the proceeds
of Omega’s offering of $175 million aggregate principal amount of its 7% senior
notes due 2016.
The
percentage of consents received exceeds the requisite consents needed to amend
the indenture pursuant to which the Notes were issued (the “Indenture”) as set
forth in the Offer to Purchase and Consent Solicitation Statement circulated
in
connection with the tender offer and consent solicitation for the Notes. As
described in the Offer to Purchase and Consent Solicitation Statement, the
amendments to the Indenture (the “Proposed Amendments”) will, among other
things, eliminate (i) all events of default under the Indenture other
than
events of default relating to the failure to pay principal of and interest
on
the Notes and to make a change of control tender offer if such offer is required
under the Indenture and (ii) eliminate substantially all of the restrictive
covenants in the Indenture and the Notes. As a result of the receipt of the
requisite consents, Omega and Wachovia Bank, National Association, as trustee
under the Indenture, have executed a supplemental indenture to the Indenture
to
affect the Proposed Amendments. The supplemental indenture has an effective
date
of December 30, 2005.
Deutsche
Bank Securities Inc. is the dealer manager for the offer to purchase and the
solicitation agent for the consent solicitation. Questions or requests for
assistance may be directed to Deutsche Bank Securities Inc. (telephone: (212)
250-4270 (collect) or toll-free at (800) 553-2826). Requests for documentation
may be directed to MacKenzie Partners, Inc., the information agent (telephone:
(212) 929-5500 (collect)) or toll-free at (800) 322-2885.
Omega’s
Board of Directors also authorized the redemption of all outstanding Notes
that
are not otherwise tendered to and accepted by Omega in connection with the
offer
to purchase and consent solicitation for the Notes. The redemption date for
the
Notes will be January 18, 2006. The aggregate redemption price plus all accrued
and unpaid interest for the Notes is $1,066.13 per $1,000 principal amount
of
Notes. In accordance with the Indenture, the Company will cause to be deposited
with the trustee the aggregate redemption price, to be held in trust for the
benefit of the holders of the Notes. On and after the redemption date, the
Notes
shall cease to be outstanding, interest thereon shall cease to accrue, and
all
rights with respect to the Notes shall cease and terminate, except for the
right
of the holders thereof to receive the redemption price of the Notes redeemed,
but without interest, upon surrender of their Notes. The notice of redemption
will be mailed to the holders of the Notes on or about December 30, 2005. The
trustee will act as the Company’s redemption and paying agent. Holders of the
Notes who hold Notes through The Depository Trust Company will have their Notes
redeemed in accordance with The Depository Trust Company’s procedures.
This
press release does not constitute a call for redemption of the Notes. Such
call
for redemption will be made in a redemption notice issued to the holders of
the
Notes by Omega.
*
* * * *
*
Omega
is
a real estate investment trust investing in and providing financing to the
long-term care industry. At September 30, 2005, the Company owned or held
mortgages on 216 skilled nursing and assisted living facilities with
approximately 22,407 beds located in 28 states and operated by 38 third-party
healthcare operating companies.
FOR
FURTHER INFORMATION, CONTACT
Bob
Stephenson, CFO at (410) 427-1700 or
visit
the
Company’s website at www.omegahealthcare.com
________________________
This
announcement
includes forward-looking statements. All forward-looking statements included
herein are based on current expectations and speak only as of the date of such
statements. Omega undertakes no obligation to publicly update or revise any
forward-looking statement, whether as a result of future events, new information
or otherwise. Such forward-looking statements should be regarded solely as
reflections of Omega's current operating plans and estimates. Statements
regarding future events and developments, including
the completion of the notes offering,
and
Omega’s future performance, as well as management's expectations, beliefs,
plans, estimates or projections relating to the future, are forward-looking
statements within the meaning of these laws. All forward-looking statements
are
subject to certain risks and uncertainties that could cause actual events to
differ materially from those projected. Management believes that these
forward-looking statements are reasonable; however, you should not place undue
reliance on such statements. Actual results may differ materially from those
reflected in such forward-looking statements as a result of a variety of
factors, including, among other things: (i) uncertainties relating to the
business operations of the operators of Omega’s properties, including those
relating to reimbursement by third-party payors, regulatory matters and
occupancy levels; (ii) regulatory and other changes in the healthcare sector,
including without limitation, changes in Medicare reimbursement; (iii) changes
in the financial position of Omega's operators; (iv) the ability of operators
in
bankruptcy to reject unexpired lease obligations, modify the terms of Omega’s
mortgages, and impede the ability of Omega to collect unpaid rent or interest
during the pendency of a bankruptcy proceeding and retain security deposits
for
the debtor's obligations; (v) the availability and cost of capital; (vi)
competition in the financing of healthcare facilities; and (vii) other factors
identified in Omega’s filings with the Securities and Exchange
Commission.